|
Volumn 99, Issue 10, 1999, Pages 1277-
|
FDA panel votes against approval for bivalirudin.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBIN;
DRUG DERIVATIVE;
HEPARIN;
HIRUDIN DERIVATIVE;
HIRULOG;
PEPTIDE FRAGMENT;
RECOMBINANT PROTEIN;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MULTICENTER STUDY;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNITED STATES;
UNSTABLE ANGINA PECTORIS;
ANGINA, UNSTABLE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
ANTITHROMBINS;
CLINICAL TRIALS;
DRUG APPROVAL;
HEMORRHAGE;
HEPARIN;
HIRUDIN THERAPY;
HIRUDINS;
HUMANS;
MULTICENTER STUDIES;
PEPTIDE FRAGMENTS;
RECOMBINANT PROTEINS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0033574099
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.99.10.1277 Document Type: Article |
Times cited : (4)
|
References (0)
|